Company intelligence / Profile preview
Papyrus Therapeutics
West Chester, Pennsylvania, United Statespapyrustherapeutics.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Papyrus Therapeutics is developing first-in-class extracellular tumor suppressor therapies, with its lead candidate PYTX‑004 (a recombinant OPCML-Fc fusion) at the IND-enabling stage. The company’s approach targets over 50% of solid tumors and aims to overcome resistance seen with traditional RTK inhibitors by restoring normal RTK signaling at the cell surface. Clinical data generation is expected to begin in approximately two years. Early preclinical collaborations are ongoing with partners such as Oxford Biomedica and Targovax, exploring synergy with CAR-T and oncolytic virus platforms.[1][3][5][6]
- Therapeutic areas
- Oncology
- Modalities
- Recombinant protein therapeuticsFusion proteinsOncolytic virusesCAR-T cell therapies[5][7]
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Oxford Biomedica (CAR-T collaboration)[5]Targovax ASA (oncolytic virus collaboration)[6]
Beyond the preview
Go deeper on Papyrus Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Papyrus Therapeutics.